These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein. Iwata K; Seya T; Ariga H; Nagasawa S J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647 [TBL] [Abstract][Full Text] [Related]
4. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis. Brooimans RA; van Wieringen PA; van Es LA; Daha MR Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224 [TBL] [Abstract][Full Text] [Related]
5. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue. Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294 [TBL] [Abstract][Full Text] [Related]
6. Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1. Seya T; Okada M; Hara T; Matsumoto M; Miyagawa S; Oshimura M Immunology; 1991 Dec; 74(4):719-24. PubMed ID: 1723716 [TBL] [Abstract][Full Text] [Related]
7. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells. Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580 [TBL] [Abstract][Full Text] [Related]
8. The control of hyperacute rejection by genetic engineering of the donor species. White DJ; Cozzi E; Langford G; Oglesby T; Wang MW; Wright L; Wallwork J Eye (Lond); 1995; 9 ( Pt 2)():185-9. PubMed ID: 7556715 [TBL] [Abstract][Full Text] [Related]
9. Expression of human DAF and MCP on pig endothelial cells protects from human complement. Carrington CA; Richards AC; Cozzi E; Langford G; Yannoutsos N; White DJ Transplant Proc; 1995 Feb; 27(1):321-3. PubMed ID: 7533398 [No Abstract] [Full Text] [Related]
10. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells. Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040 [TBL] [Abstract][Full Text] [Related]
11. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis. Matsumoto M; Sugita Y; Seya T Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391 [TBL] [Abstract][Full Text] [Related]
12. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59. Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913 [TBL] [Abstract][Full Text] [Related]
13. Effect of tandem forms of DAF(CD55) on complement-mediated xenogeneic cell lysis. Miyagawa S; Fukuta D; Kitano E; Kobayashi C; Fumimoto Y; Shirasu A; Hattori H; Shirakura R; Fukuzawa M Xenotransplantation; 2006 Sep; 13(5):433-9. PubMed ID: 16925667 [TBL] [Abstract][Full Text] [Related]
14. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603 [TBL] [Abstract][Full Text] [Related]
15. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis. Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608 [TBL] [Abstract][Full Text] [Related]
16. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59. Kennedy SP; Rollins SA; Burton WV; Sims PJ; Bothwell AL; Squinto SP; Zavoico GB Transplantation; 1994 May; 57(10):1494-501. PubMed ID: 7515200 [TBL] [Abstract][Full Text] [Related]
17. The effect of complement regulatory protein expression on pig endothelial cells to porcine endogenous retrovirus lyses by human sera. Hazama K; Miyagawa S; Yamamoto A; Kubo T; Miyazawa T; Tomonaga K; Watanabe R; Okumura M; Matsuda H; Shirakura R Transplant Proc; 2005; 37(1):503-5. PubMed ID: 15808690 [TBL] [Abstract][Full Text] [Related]
18. Differential human serum-mediated neutralization of PERV released from pig cells transfected with variants of hDAF. Okura E; Ishimaru A; Yamamoto A; Nakatsu S; Shirakura R; Okabe M; Sawa Y; Fukuzawa M; Okumura M; Miyagawa S Xenotransplantation; 2008; 15(6):365-73. PubMed ID: 19152664 [TBL] [Abstract][Full Text] [Related]
19. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation. Capey S; van den Berg CW Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772 [TBL] [Abstract][Full Text] [Related]
20. Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejection. Lazzeri M; Mora M; Mulder LC; Marsicano G; Marinucci G; Boschi M; Bruzzone P; Alfani D; Cortesini R; Rossini M J Urol; 1998 Apr; 159(4):1364-9. PubMed ID: 9507885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]